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ChitosanhLF1–11 (GRRRRSVQWCA) is an antimicrobial peptide (AMP) with high activity against methicillin-resis-
tant Staphylococcus aureus (MRSA), the most prevalent species in implant-associated infection. In this
work, the effect of the surface immobilization on hLF1–11 antimicrobial activity was studied. Immobili-
zation was performed onto chitosan thin ﬁlms as a model for an implant coating due to its reported oste-
ogenic and antibacterial properties. Chitosan thin ﬁlms were produced by spin-coating on gold surfaces.
hLF1–11 was immobilized onto these ﬁlms by its C-terminal cysteine in an orientation that exposes the
antimicrobial activity-related arginine-rich portion of the peptide. Two levels of exposure (with and
without a polyethylene glycol (PEG) spacer) were analyzed. Covalent immobilization was further com-
pared with the AMP physical adsorption onto chitosan ﬁlms. Surfaces were characterized using ellipsom-
etry, contact angle measurements, atomic force microscopy, infrared and X-ray photoelectron
spectroscopies and using a ﬂuorimetric assay for hLF1–11 quantiﬁcation. Surface antimicrobial activity
was assessed through surface adhesion and viability assays using an MRSA (S. aureus ATCC 33591).
The incorporation of hLF1–11 increased signiﬁcantly bacterial adhesion to chitosan ﬁlms. However, the
presence of hLF1–11, namely when immobilized through a PEG spacer, decreased the viability of adher-
ent bacteria with regard to the control surface. These results demonstrated that hLF1–11 after covalent
immobilization by its cysteine can maintain activity, particularly if a spacer is applied. However, further
studies, exploring the opposite orientation or the same C-terminal orientation, but non-cysteine related,
can help to clarify the potential of the hLF1–11 immobilization strategy.
 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.1. Introduction
Antimicrobial peptides (AMPs) are a new class of antibiotics
with very promising characteristics. They are usually composed
of short sequences of amino acids (<50 residues), with simulta-
neous amphipathic and cationic behaviors [1]. Although the AMPs’
exact mechanism of action is not fully elucidated, it is generally
accepted to include electrostatic interactions between the bacte-
rium negatively charged outer layer and the positively charged
AMP, which results in bacterial death [1,2]. Their most interesting
features are: high activity against a broad spectrum of microorgan-
isms (Gram-positive and –negative bacteria, yeasts), high selectiv-ity towards microorganisms and not mammalian cells (which have
zwitterionic membranes), fast killing even at low concentrations
and, most importantly, they do not have the tendency to induce
resistance [1,3]. This last feature differentiates them from the clas-
sical antibiotics presently used. However, AMP application has
some associated challenges, namely (i) proteolytic degradation,
(ii) peptide co-precipitation with plasma carrier proteins and (iii)
peptide self-aggregation. Also, if higher titers are applied to cir-
cumvent such problems, cytotoxic effects become apparent. One
current strategy to overcome these challenges is its covalent
immobilization onto a surface [4].
In the present work we have chosen hLF1–11, which is a 11-mer
derived from human Lactoferrin. This amphipathic peptide, with
an hydrophilic N-terminal and a hydrophobic C-terminal, has a
wide spectrum of activity, associated with an excellent safety pro-
ﬁle, tested both in vitro and in vivo [5–7]. Indeed, it has been tested
against methicillin-resistant Staphylococcus aureus (MRSA) in an
osteomyelitis model [8–10]. However, in this model, the delivery
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(Ca–P) cement, which resulted in burst peptide release only [11].
Likewise, Kazemzadeh-Narbat et al. [12] tested hLF1–11 on a
Ca–P microporous coating and found the peptide to have a slow
and incompetent release. Therefore, as the soluble hLF1–11 appli-
cation has not provided sufﬁcient activity, we decided to test
whether covalent immobilization could originate an efﬁcient anti-
microbial coating against implant-related infections. To this end,
we needed a polymer that would be easily functionalized, but also
would have intrinsic characteristics favorable to the product end
application, as allowing osteointegration, and inhibiting bacterial
adhesion and growth. Therefore, we chose chitosan, as it fulﬁlls
the characteristics mentioned above, with reported antimicrobial
[13–16] and osteogenic properties [17–20]. As summarized by us
[4], AMP covalent immobilization may result in activity lost, so
some parameters should be addressed in order to obtain maximum
activity, namely (i) orientation (N- or C-terminal immobilization)
and (ii) exposition. The combination of these parameters gives rise
to different immobilization proﬁles that can have very distinct
activities. Some papers have reported that positively charged ami-
no acids (arginine) of its N-terminal are essential for hLF1–11 anti-
microbial activity [6,7,21]. Also, the natural sequence of hLF1–11
offers a free sulfhydryl group at the cysteine residue near the
C-terminal, which can be used for disulﬁde bridge establishment
with SH-modiﬁed chitosan. This is a simple, mild reaction that
allows the control of peptide orientation. Therefore in this study,
we immobilize hLF1–11 by its C-terminal (exposing the arginine/
positive end) directly to the polymer (for a more strict and oriented
exposition of the AMP) or through a spacer (for a more movable/
ﬂexible exposition) and compare its activity against simple physi-
cal adsorption of the peptide onto the polymer.2. Materials and methods
2.1. hLF1–11 synthesis and characterization
hLF1–11 (GRRRRSVQWCA, C-terminal amide) was produced by
Fmoc/tBu solid-phase peptide synthesis methodologies assisted
with microwave energy (Liberty 1 Microwave Peptide Synthesizer,
CEM Corporation) [22,23]. Crude product was puriﬁed by reverse-
phase liquid chromatography and conﬁrmed by high-performance
liquid chromatography (Hitachi-Merck LaChrom Elite), liquid chro-
matography–electrospray ionizationmass spectrometry (LCQ-DecaXP
LC-MS system, ThermoFinnigan) and ultraviolet spectrometry. The
peptide used presented a purity level higher than 90%.
2.2. hLF1–11 surface immobilization
2.2.1. Substrate preparation
Au production and cleaning were performed according to
Martins et al. [29]. Brieﬂy, chromium (5 nm) and gold (25 nm) layers
were deposited by ion beam sputtering from chromium and gold
targets (99.9% purity) on silicon wafers (AUREL, GmbH). Chromium
was used to improve the adhesion of gold to silicon. Gold sub-
strates were cleaned with ‘‘piranha’’ solution (7 parts of H2SO4
and 3 parts of 30% H2O2) for 5 min (caution: this solution reacts
violently with many organic materials and should be handled with
suitable protective measures), thoroughly rinsed with ethanol and
dried with a gentle stream of argon.
2.2.2. Preparation of chitosan ultrathin ﬁlms
Commercial squid pen chitosan (France Chitine) was puriﬁed by
the reprecipitation method [25]. Chitosan thin ﬁlms were prepared
by dispensing a drop of chitosan solution (0.4% in acetic acid w/v)
[26] on the center of the Au substrates (150 ll for 1  1 cm2 sub-strates) placed in the spin coater equipment (Laurell Technologies
Corporation) and spun at 9000 rpm for 1 min. Then, the newly pre-
pared ultrathin ﬁlms were neutralized with 0.1 M NaOH for 5 min
and rinsed twice with MilliQ water. Each sample was dried with a
gentle stream of argon and stored in sealed plastic Petri dishes sat-
urated with argon until use.
2.3. Peptide immobilization
hLF1–11 immobilization on chitosan thin ﬁlms was performed
by forming a persulfate bond (disulﬁde bridge) between free sulf-
hydryl groups present in the peptides cysteine side chain and in
pre-functionalized chitosan (Fig. 1).
2.3.1. Introduction of SH groups onto chitosan ﬁlms
Functionalization of chitosan thin ﬁlms with SH groups was
obtained by the coupling of N-acetyl cysteine (NAC) (Merck), or
O-(2-carboxyethyl)-o’-(2-mercaptoethyl) heptaethylene glycol
(Sp) (Sigma AldrichP95% purity). Chitosan thin ﬁlms were treated
with a solution of 0.2 M 1-ethyl-3-(3-dimethylaminopropyl)car-
bodiimidehydrochloride) (EDC; Sigma–Aldrich), 0.05 M N-hydrox-
ysulfosuccimide (NHS; Sigma–Aldrich) and 25 mM of SH agent
(NAC or Sp) in 0.1 M (N-morpholino)ethanesulfonic acid (MES;
Sigma–Aldrich) buffer at pH 6.5 for 1 h (NAC) or 2 h (Sp), at 37 C
and 100 rpm. Samples were then rinsed withMilliQ water, immersed
for 1 min in an ultrasound bath (Bandelin Sonorex Digitec Bath
35 kHz) and rinsed again with MilliQ water.
2.3.2. Peptide chemical and physical immobilization
Non-modiﬁed (for simple physical adsoption) and modiﬁed
chitosan substrates were incubated with 1 mg ml1 peptide solu-
tion in 10 mM TrisHCl, pH 8.0, in oxidative conditions (20%
dimethyl sulfoxide (DMSO)) for 18 h, at 30 C and 120 rpm.
2.4. Surface characterization
2.4.1. Infrared reﬂection absorption spectroscopy (IRRAS)
Measurements were performed on a Perkin Elmer Fourier trans-
form infrared spectrophotometer, model 2000, coupled to a
VeeMax II Accessory (PIKE) and a liquid-nitrogen-cooled mercury
cadmium telluride (MCT) detector. In order to ensure that there
was no water vapor adsorption, dry nitrogen was purged into the
instrument for 5 min before and during the measurement of each
sample. For each substrate, a similar gold surface was used as a
background. Incident light was p-polarized and spectra were
collected using the 80 grazing angle reﬂection mode. For each
sample, 100 scans were collected with 4 cm1 resolution.
2.4.2. Ellipsometry
Ellipsometry measurements were performed using an imaging
ellipsometer, model EP3, from Nanoﬁlm Surface Analysis.
This ellipsometer was operated in a polarizer–compensator–
sample–analyzer mode (null ellipsometry). The light source was a
solid-state laser with a wavelength of 532 nm. The gold substrate
refractive index (n = 0.6244) and extinction coefﬁcient (k = 2.3845)
were determined using a delta and psi spectrum with a variation
of angle between 65 and 71. These measurements were made in
four zones to correct for any instrument misalignment. The thick-
ness of the chitosan ﬁlms was determined using (n) chitosan = 1.54
and (k) chitosan = 0 [27]. Results are presented as the average of
three measurements on each of two samples.
2.4.3. X-ray photoelectron spectroscopy (XPS)
XPS measurements were carried out on a VG Scientiﬁc Escalab
200A (UK) spectrometer using magnesium Ka (1253.6 eV) as
the radiation source (from CEMUP – Centro de Materiais da
Fig. 1. (A) Chitosan modiﬁcation with NAC or Sp; (B) hLF1–11 immobilization by establishment of a covalent disulﬁde bridge.
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take-off angle of 55. Survey spectra were collected over a range
of 0–1150 eV with an analyzer pass energy of 50 eV. High-resolu-
tion C1s, O1s, N1s, S2p and Au4f spectra were collected with an
analyzer pass energy of 20 eV. The binding energy (BE) scales were
referenced by setting the C1s BE to 285.0 eV. All the spectra were
ﬁtted using XPS peak ﬁtting software (XPSPEAK Version 4.1). Ele-
ment atomic percentages were calculated from the integrated
intensities of the XPS peaks, taking into account the atomic sensi-
tivity factors of the instrument data system. Sulfur high resolution
spectra were ﬁtted with a doublet structure with a 2:1 area ratio
and splitting of 1.2 eV, as described by Castner et al. [28]. All sulfurspectra were ﬁtted with a 1.7 eV full width at half maximum
proﬁle.
2.4.4. Water contact angle measurements
Contact angle measurements were performed using the sessile
drop method with a contact angle measuring system from Data
Physics, model optical contact angle (OCA) 15, equipped with a vi-
deo CCD camera and SCA 20 software, as described byMartins et al.
[29]. After deposition of 4 ll drops of MilliQ water, images were ta-
ken every 2 s over 300 s. Droplet proﬁles were ﬁtted using different
mathematical functions, to calculate the contact angle. The ellipse
ﬁtting method was used to calculate contact angles between 90
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by extrapolating the time-dependent curve to zero. Results are the
average of three measurements on three independent samples.
2.4.5. Atomic force microscopy (AFM)
AFM studies were carried out using a PicoPlus scanning probe
microscope interfaced with a Picoscan 2500 controller (both from
Agilent Technologies, USA). Each sample was imaged with a
10  10 lm2 piezo-scanner. The surface roughness was deter-
mined in 700  700 nm2 scanned areas in ﬁve randomly chosen
locations per sample, at room temperature. The roughness height
parameter calculated was the root mean square roughness, which
corresponds to the deviations from the center x–y plane (Rq). The
center plane is a plane such that the volumes enclosed by the
image surface above and below are equal. The control gold sub-
strate was analyzed through Tapping mode, with a spring con-
stant of K = 1–5 N m1 using a silicon tip. Samples were analyzed
in contact mode, using a silicon nitride tip with a spring constant
of K = 0.58 N m1.
2.4.6. Peptide surface density
Tethered peptide quantiﬁcation was performed through colori-
metric reaction using 9,10-phenanthrenequinone (PHQ, Fluka)
[30]. The reaction between PHQ and arginine or arginine residues
forms a stable compound which ﬂuoresces upon excitation [30].
Present protocol was adapted from Kazemzadeh-Narbat et al.
[12] Substrates were sonicated 1 h in 0.1 M HCl in an ultrasound
bath. Then, 1 ml of each sample solution was added to 3 ml of
3.5 lM PHQ in absolute ethanol. Simultaneously 0.5 ml of 2 M
NaOHwas added to adjust the pH. The mixture was then incubated
at 30 C for 3 h. Finally, 2.25 ml of 2.4 M HCl was added to stop the
reaction. At this point, the characteristic wavelengths were deter-
mined from the excitation and emission spectra. The highest emis-
sion intensity was found at the wavelength of 380 nm. The highest
peak at the excitation spectrum (256 nm) was chosen for the max-
imum emission output. The ﬂuorescence emission was measured
using a ﬂuorescence microplate reader (Biotek Synergy Mx Lumi-
nometer). The amount of hLF1–11 was calculated based on a cali-
bration curve prepared with standard solutions of free L-arginine
(Fluka) and free hLF1–11. Standard solutions of free hLF1–11
were adjusted by quantiﬁcation at 280 nm in a Thermo Scientiﬁc
‘‘Nanodrop 1000’’ spectrophotometer.
2.5. Bacterial assays
2.5.1. Bacterial strains, media and growth conditions
Methicillin-resistant S. aureus Subsp aureus strains (ATCC
33591) were obtained from the American Type Culture Collection.
Bacteria were grown on tryptic soya agar (TSA) (Merck) and tryptic
soya broth (TSB) (Merck). Bacterial suspensions were adjusted by
measuring optical density (600 nm). Bacterial numbers were con-
ﬁrmed by a colony forming units (CFUs) count.
2.5.2. Minimal inhibitory concentration determination
Minimal inhibitory concentration (MIC) was established with a
modiﬁed broth microdilution method in Mueller Hinton broth
(MHB) [31].
2.5.3. Bacterial–surface interaction
2.5.3.1. Sample preparation. Test surfaces were washed successively
in 70% ethanol and sterile water, and then dried in sterile environ-
ment. Samples were then transferred to a 24-well, ﬂat-bottom
cellular suspension plates (Sarstedt, Ltd, Newton, USA).
2.5.3.2. Sample incubation with bacteria. 500 ll of 3  107 CFU ml1
bacterial solution (S. aureus ATCC 33591) was then added to eachwell and incubated at 37 C for 4 h. Surrounding wells were ﬁlled
with 1 ml of sterilized deionized water, in order to avoid broth
evaporation.
2.5.3.3. Non-adherent viable bacteria (supernatant) assay. After the
incubation period, serial dilutions of the supernatants were per-
formed and plated onto TSA plates. CFU counts were assessed after
18 h incubation at 37 C.
2.5.3.4. Bacterial surface adhesion assay. After the incubation period,
substrates were rinsed with phosphate buffered saline (PBS) sterile
solution, and then ﬁxed with 300 ll of paraformaldehyde 4% for
20 min. Substrates were rinsed again with sterile PBS solution
and stained with VECTASHIELD Mounting Medium with (40,6-
diamidino-2-phenylindole (DAPI; Vector). DAPI binds to bacteria
DNA, is excited at 360 nm and emits at 460 nm, resulting in
blue ﬂuorescence. Images were obtained with an inverted ﬂuores-
cence microscope (Axiovert 200 M, Zeiss, Germany) using a magni-
ﬁcation of 1000, corresponding to a net surface area of
0.1181 mm2 per sample. For quantifying the total adherent bac-
teria, eight ﬁelds of each sample were obtained and analyzed using
ImageJ software. The image analysis results were measured as the
average area of cells per ﬁeld of view, and are reported as the aver-
age percentage coverage. Three replicates for each condition were
used.2.5.3.5. Viable surface adherent bacteria assay. After the incubation
period, substrates were rinsed with PBS sterile solution to remove
non-adherent bacteria, transferred to a new plate with 500 ll of
PBS and then sonicated for 8 min in an ultrasound bath (Bandelin
Sonorex Digitec Bath 35 kHz) to release all adherent bacteria. After
sonication, serial dilutions of the supernatant were performed, and
plated onto TSA. CFU counts were performed after 18 h of incuba-
tion at 37 C. Three replicates for each condition were used. To con-
trol sonication efﬁciency, the sonicated substrates were stained
with VECTASHIELD Mounting Medium with DAPI and observed
using a inverted ﬂuorescence microscopy, to guarantee that all
bacteria were removed from the surface. Also, the initial inoculum
was plated before and after sonication, to ensure that minimum
death was promoted by the technique.2.6. Statistical analysis
For statistical analysis, one-way analysis of variance followed
by Tukey’s post hoc testing were used. When Gaussian distribution
was not conﬁrmed (Antimicrobial activity assays) the non-
parametric Kruskal–Wallis test was applied using the Graphpad
Prism program. Data are expressed as the mean ± standard devia-
tion (SD) and p values of <0.05 were considered signiﬁcant.3. Results
3.1. Surface characterization
Chitosan thin ﬁlms with and without hLF1–11 were character-
ized using ellipsometry, water contact angle measurements, AFM,
IRRAS, XPS and ﬂuorimetric assay.3.1.1. Ellipsometry
The thickness of the spin-coated chitosan ﬁlms was
14.6 ± 1.4 nm. Films remained stable during reaction procedures,
since no thickness differences were detected between freshly and
buffer incubated ﬁlms (data not shown). Fig. 2A shows the thick-
ness of chitosan thin ﬁlms after surface modiﬁcation. The thickness
Fig. 2. Surface characterization of chitosan-modiﬁed ﬁlms as determined by (A) ellipsometry (surface thickness); (B) water optical contact angle measurements; (C) AFM
(surface roughness).
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(+9.8 nm) or Sp (+20.5 nm) (p < 0.05), which is proportional to
the length of the immobilized structure, suggesting the success
of the functionalization. After hLF1–11 immobilization onto
Chit_NAC (Chit_NAC_hLF), a 2 nm thickness increase was observed
(p < 0.05), indicating that the peptide was successfully bonded to
the polymer. However, hLF1–11 immobilization onto Chit_Sp was
not detected using this technique, since no signiﬁcant difference
was observed between the Chit_Sp ﬁlm thickness before and after
peptide immobilization (Chit_Sp_hLF). This can be explained by
the ﬂexibility of the spacer, which can result in a closer positioning
of the peptide towards the chitosan ﬁlm or due to the SS bond for-
mation between the SH terminal of the Sp. The small increase from
14.6 ± 1.4 nm to 17.1 ± 0.4 nm observed in chitosan ﬁlms after
immersion in the peptide solution indicates that some hLF1–11
can be adsorbed or incorporated onto chitosan ﬁlms (p < 0.05).
No signiﬁcant thickness difference was observed between chitosan
solely incubated with EDC/NHS reagents and Chit_NAC. This
situation can be explained by an alternative chemistry pathway
where the absence of a carboxylic group allows a direct reaction
of the carbodiimide of EDC with the free amine groups of chitosan
[33].
3.1.2. Water contact angle measurements
Water contact angle of chitosan surfaces before and after chem-
ical modiﬁcation is shown in Fig. 2B. Chitosan ﬁlms (hw = 64 ± 2)
became more hydrophilic after NAC and Sp functionalization
(hw = 37 ± 2 and 49 ± 1, respectively) in contrast with the EDC/
NHS modiﬁcation (hw = 58 ± 1). After hLF1–11 direct immobiliza-
tion onto Chit_NAC (Chit_NAC_hLF), the water contact angle in-
creased to 40 ± 0.1 (p < 0.05), suggesting peptide immobilization
onto the polymer. However, surface wettability was not changed,
when hLF1–11 was immobilized to Chit_Sp (Chit_Sp_hLF). hLF1–
11 adsorption onto chitosan was also not detected using this
technique.3.1.3. AFM
Alteration of surface roughness due to the successive chemical
modiﬁcations on chitosan was analyzed by AFM, as presented in
Fig. 2C. AFM allowed the observation of peptide incorporation on
both NAC- and Sp-modiﬁed chitosan, as the root mean square
roughness of Chit_NAC_hLF and Chit_Sp_hLF was respectively
41% and 64% higher (p < 0.05) than that of the corresponding chito-
san modiﬁed substrate. No other signiﬁcant differences were found
between the remaining samples.
3.1.4. IRRAS
IRRAS spectra of chitosan thin ﬁlms before and after covalent
immobilization of NAC and Sp are shown in Fig. 4.
The spectrum of chitosan immersed in buffer (Chit_b) allows
the identiﬁcation of the characteristic absorption bands of chito-
san, as described elsewhere [25,26,34–36]. After reaction with
NAC and Sp, the increase of the characteristic amide I IR absorption
(1660 cm1) conﬁrms the covalent reaction between chitosan free
amine groups and the terminal carboxylic groups of NAC or Sp.
Chitosan incubated with EDC/NHS reagents also presented a simi-
lar peak augmentation (data not shown) in the same region, which
is consistent with the mentioned alternative chemical pathway (on
Fig. 3) involving the formation of an imine intermediate (C@N
stretching typically ranges from 1690 to 1630 cm1) [37]. The C–
H stretching peak at 2876 cm1 was masked on the Chit_NAC
and Chit_NAC_hLF samples, but it was slightly increased in the
Chit_Sp sample, as expected from the seven ethylene units from
the polyethylene (PEG) spacer. Sp-modiﬁed samples have also
shown a slightly deviated peak, from 1080 cm1 to 1114 cm1,
attributed to C–O–C stretching vibration on a straight chain (of
the spacer) instead of a glucopyranose ring (of chitosan). Spectra
from chitosan thin ﬁlms obtained after hLF1–11 adsorption or
immobilization are shown in Fig. 4. In all cases, hLF1–11 peptide
could be detected through an increase of the amide I peak
(1660 cm1) characteristic of peptides/proteins. However, chitosan
Fig. 3. Reaction of carbodiimide (EDC) and NHS with chitosan free amines.
Fig. 4. IRRAS spectra of chitosan modiﬁed ﬁlms and hLF1–11 immobilized chitosan
ﬁlms.
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tion band. Therefore, to assess hLF1–11 immobilization, a peak
height ratio (amide I peak height (1660 cm1)/C–O–C peak height
(1080 cm1)) was calculated for NAC-derived samples, since Sp
samples have signal overlap at the 1080 cm1 band. A higher peak
ratio was found on immobilized peptide samples (4.62) than on the
NAC samples (2.71), suggesting peptide immobilization. The slight
decrease in the C–O–C vibration peak (1080 cm1) of chitosan ﬁlms
(Chit_b) after immersion in the hLF1–11 solution (Chit hLFads) also
demonstrated that some hLF1–11 was adsorbed or incorporated
onto chitosan.
3.1.5. XPS
XPS survey spectra demonstrated the absence of contaminants
on the ﬁlms, since no other elements than the expected ones were
detected (data not shown). The relative atomic composition of
chitosan ﬁlms (Chit_b) is in accordance with previous reports
[26,36]. XPS S2p high-resolution spectra were used to detect chem-
ical modiﬁcations, since immobilization reactions were performed
using sulfur bonds. Table 1 shows the percentage of S2p involved in
the different chemical bonds, free thiol groups (163 eV), disulﬁde
(164–165 eV) and oxidized sulfur species (168–169 eV). S2p was
only detected on covalently modiﬁed chitosan ﬁlms. Peptide
immobilization was conﬁrmed by the increase in the total sulfur
percentage with regard to the controls (Chit_NAC and Chit_Sp),
speciﬁcally the sulfur assigned to the establishment of the disulﬁde
bridge (164–165 eV). However, some disulﬁde bonds were also ob-
served on the Chit_Sp sample, which can be explained by the ﬂex-
ibility and mobility of the SH-terminated spacer chains. Adsorbed
hLF was not detected using this technique, since no sulfur was
observed on the Chit_hLFads sample. With the exception ofChit_NAC_hLF, some oxidized sulfur was always found, due to its
exposition on the surface.3.1.6. Peptide ﬂuorimetric quantiﬁcation
A ﬂuorimetric technique was used to assess hLF1–11 surface
density: Chit_NAC_hLF 6.4 (±1.4) ng mm2, Chit_Sp_hLF 4.9
(±0.8) ng mm2 and Chit hLF ads 3.7 (±1.0) ng mm2. These results
present the same tendency observed on the other characterization
techniques, although no statistically signiﬁcant differences were
observed between samples.3.2. Antimicrobial activity characterization
The MIC of the soluble hLF1–11 was 64 lg ml1 for the tested S.
aureus strain.
Fig. 5A shows the non-adherent viable bacteria (supernatant)
after contact for 4 h with the different surfaces. No signiﬁcant dif-
ferences were found between the CFUs of the supernatants of wells
with and without samples, except for the gold surface (blank)
where a decrease in the number of viable bacteria was observed.
Comparing between samples, the number of CFUs on the superna-
tant of the gold surface was only signiﬁcantly different from
Chit_Sp.
Fig. 5B shows that a thin ﬁlm of chitosan decreases bacterial
adhesion to the gold surface (blank). In contrast, the presence of
hLF1–11 induced bacterial adhesion to chitosan, particularly when
the peptide was directly immobilized on chitosan (Chit_NAC_hLF)
(46-fold higher (p < 0.05)). When analyzing the viable adhered bac-
teria (Fig. 5C), hLF1–11 incorporation only increased signiﬁcantly
the number of viable bacteria onto chitosan ﬁlms when the peptide
was physically adsorbed onto the surface (Chit hLFads) or immobi-
lized through NAC (Chit_NAC_hLF) (p < 0.05). However, although
bacteria adhesion on Chit_NAC_hLF was 1.7 times higher than
on the blank surface, the number of viable adherent bacteria be-
tween these two surfaces was similar. When hLF1–11 immobiliza-
tion occurred through a PEG spacer (Chit_Sp_hLF), it was possible
to observe a similar surface coverage (Fig. 5B) but a much lower
number of viable bacteria (80%) than the blank (p < 0.05)
(Fig. 5C).
Fig. 6 shows one representative image of the adherent bacteria
on each sample. Bacteria adhesion was uniformly distributed when
hLF1–11 was physically adsorbed onto chitosan ﬁlm. However,
when covalently immobilized, adherent bacteria appeared
clumped together.
These results demonstrated that immobilization of hLF1–11 by
its cysteine residue leads to a loss of activity. However, hLF1–11
was still able to attract and bind S. aureus and kill about half of
adherent bacteria, particularly when immobilized through a
spacer.
Table 1
S2p relative surface atomic composition of different chitosan samples.
Chitosan
samples
S2p (%) S2p (at.%)
163 eV S-H 164–165 eV S-S 168–169 eV SO3
Chit_b 0 0 0 0
Chit_EDC/
NHS
0 0 0 0
Chit_NAC 0.8 67 0 33
Chit_NAC_hLF 1.7 18 82 0
Chit_Sp 0.9 33 56 11
Chit_Sp_hLF 1.7 18 64 18
Chit hLFads 0 0 0 0
Fig. 5. Antimicrobial activity characterization of chitosan-modiﬁed ﬁlms by (A) non-adh
surface coverage, and (C) viable adherent bacteria on different substrates.
Fig. 6. Representative images of the DAPI staining of the total adhered bacteria in the d
with a magniﬁcation of 1000. Scale bar corresponds to 10 lm.
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In this study, different immobilization parameters (orientation
and exposition) were assessed in the covalent immobilization of
the hLF1–11 peptide onto chitosan ultrathin ﬁlms. C-terminal
immobilization was chosen to orient the arginine-rich portion of
the peptide (associated with the antimicrobial activity [6,7,21])
towards the exterior. Also, two exposition levels (direct link and
through a spacer) were tested, in order to assess the best immobi-
lization proﬁle for this particular AMP. Surface characterization
using a number of different techniques – ellipsometry, IRRAS,
XPS, water contact angle measurements, AFM and ﬂuorimetricerent viable bacteria, (B) bacterial adhesion to different substrates in percentage of
ifferent chitosan-modiﬁed surfaces. An inverted ﬂuorescence microscope was used
3520 F. Costa et al. / Acta Biomaterialia 10 (2014) 3513–3521peptide quantiﬁcation – demonstrated that stable chitosan thin
ﬁlms with and without hLF1–11 was successfully produced. Fluo-
rimetric peptide quantiﬁcation demonstrated that different chem-
ical approaches allowed the modiﬁcation of chitosan ﬁlms with
similar amounts of peptide (ranging from 3.7 to 6.4 ng mm2) with
different exposure strategies. The covalent immobilization of
hLF1–11, either directly or through a spacer, was conﬁrmed by
XPS analysis, where the relative content of the S2p peak assigned
to the disulﬁde bridge (164–165 eV) was clearly increased. More-
over, ellipsometry, AFM and contact angle measurements offered
further support to peptide immobilization. Higher thickness and
roughness were consistently observed on surfaces with peptide
covalently immobilized, as well as an altered wettability congruent
with the chemical modiﬁcation promoted. Direct hLF1–11 immo-
bilization (Chit_NAC_hLF) was also conﬁrmed by IRRAS due to
the rise of the characteristic infrared absorption bands of proteins,
in particular, the amide I band. hLF1–11 physical adsorption onto
chitosan ﬁlms was not detected by water contact angle measure-
ments or XPS analysis (no S2p). However, a slightly thicker ﬁlm
(17.1 nm) was observed when compared to control chitosan ﬁlm
(14.6 nm) and the slight decrease on the chitosan C–O–C vibration
peak at 1080 cm1, determined by IRRAS, conﬁrms some peptide
adsorption.
Antimicrobial activity of soluble hLF1–11 was ﬁrstly tested
against ATCC 33591 S. aureus strain, as this species is the most pre-
valent in implant-related infections [8,38]. This S. aureus strain
presented a minimum inhibitory concentration of 64 lg ml1. This
value is higher than that reported elsewhere [5,7,21,39]. However,
since MIC values determined by different authors were performed
under different conditions, namely different incubation times and
initial inoculum, MIC values are mostly difﬁcult to compare. Dur-
ing this work, MICs were calculated using the standard conditions
described by Wiegand et al. [31].
The non-adherent viable bacteria assay revealed a uniform bac-
teria concentration over the different surfaces. The exceptions seen
were the blank gold surface, and Chit_Sp. The former lower CFU
value may be associated with a higher bacterial adhesion onto
the surface, and the later higher CFU value may be explained by
the non-fouling properties of the PEGylated surface [40,41].
Considering the bacteria adhered to the surfaces, and congruent
to previous reports [13,15], bacterial adhesion to chitosan is very
low. After chitosan functionalization with NAC and Sp, the values
of adhered bacteria remained low. The low bacterial adhesion on
Chit_NAC samples can be explained by some oxidation of the cys-
teine SH group in SO43- that, due to its negative behavior, can be
responsible for repulsive forces towards the negatively charged
bacterial membranes. It was also reported that NAC has an inhibi-
tory effect on the slime formation by Staphylococcus epidermis dur-
ing bioﬁlm formation [42]. Further studies regarding the effect of
NAC functionalized chitosan ﬁlms on bacterial bioﬁlm formation
are currently being performed in our laboratory. Chit_Sp has a
PEGylated surface, which is well known for its non-fouling proper-
ties (i.e. it prevents cell (bacterial or mammalian) adhesion)
[40,41]. The incorporation of hLF1–11 onto chitosan ﬁlms was able
to attract and bind bacteria, as expected by the orientation chosen
for covalent immobilization (exposing the arginine/positive end).
The highest value of adherent bacteria on surfaces where hLF1–
11 was directly immobilized could be related to a more rigid expo-
sition of the arginine portion of the peptide. In the particular cases
of Chit_Sp_hLF and Chit hLF ads, the enhancement of bacterial
adherence is less pronounced, which may be associated with a
more ﬂexible (chit_Sp_hLF) or more random (Chit hLF ads) exposi-
tion/orientation of the peptide. Nevertheless, when comparing the
bacterial surface coverage with the adhered viable bacteria, it is
possible to observe that, besides attracting bacteria, the peptide
maintains some antimicrobial activity, which is more evident inthe spacer modiﬁed sample (similar surface coverage with regard
to blank but a much lower number of viable bacteria (80%)
(p < 0.05)). It remains to elucidate whether a C-terminal immobili-
zation without compromising the cysteine residue would have a
more signiﬁcant activity. A number of other studies with immobi-
lized AMPs have approached the issue of AMP exposure [43–49].
For example, Gabriel et al. [44] demonstrated that the LL37 peptide
bound to titaniumwas capable of killing Escherichia coli on contact,
only when a PEGylated spacer was used. The authors suggested
that the use of a long, ﬂexible PEG spacer provided a parallel pep-
tide orientation and lateral mobility that were required for bacte-
ricidal activity. Therefore, considering the parameters analyzed,
the immobilization of hLF1–11 through a spacer renders the best
proﬁle, as it simultaneously attracts and kills bacteria.
Recently, Hilpert et al. [50] reported that, in opposition to what
was expected, immobilized AMPs that expose their hydrophobic
termini exhibit higher antimicrobial activity. It was suggested that
the hydrophobic residues could interact with the lipophilic portion
of the bacterial membrane, becoming embedded into its surface
and destabilizing the packing of the phospholipids. It was also
described that tryptophan (W) residues in AMPs could be impor-
tant for their antimicrobial activity [51], as the aromatic hydrocar-
bon residues are able to position themselves deeper into the lipid
portion of the phospholipid bilayer, making the peptide more efﬁ-
cient in disrupting/destabilizing the bacterial cell membrane [6].
Although the exact mechanism of action of hLF1–11 is still not elu-
cidated, the membrane-induced peptide conformation [52] and
high speed of action [53] suggest direct membrane disruption.
Therefore, considering an N-terminal immobilization of hLF1–11,
the hydrophobic end of the peptide would be exposed, which could
result on enhanced activity. So the hLF1–11 immobilization chap-
ter is not closed and further studies will allow conclusions to be
drawn about the hLF1–11 application in its immobilized form. In
view of the above, future work will include new immobilization
comparing non-cysteine related C-terminal with N-terminal orien-
tation through a chemistry that allows a higher yield of immobi-
lized AMP.5. Conclusion
hLF1–11 covalent immobilization was successfully performed
using speciﬁc orientation through its C-terminal cysteine, with
and without a PEG spacer in similar amounts. Chitosan thin ﬁlms
by themselves decreased bacterial adhesion. The functionalization
with hLF1–11 increases signiﬁcantly bacterial adhesion to chitosan
ﬁlms, particularly when the peptide was covalently coupled with-
out a PEG spacer. However, when a PEG spacer is used, hLF1–11
maintained part of its activity.
Acknowledgements
This work was ﬁnanced by FEDER funds through the Programa
Operacional Factores de Competitividade (COMPETE) and by Portu-
guese funds through FCT (Fundação para a Ciência e a Tecnologia)
in the framework of the projects: PTDC/CTM/101484/2008; PEst-C/
SAU/LA0002/2013. Fabíola Costa acknowledges FCT, for the PhD
grant SFRH/BD/72471/2010. We acknowledge Manuela Brás from
SUIM (INEB) for the AFM studies.Appendix A. Figures with essential colour discrimination
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